HB Wealth Management, LLC
- SEC CIK
- 0001911253
- Latest filing
- Jul 29, 2026
SABS holding history
SAB Biotherapeutics, Inc. in every 13F filed by HB Wealth Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SABS overviewAll 13F holders of SABSFull Q2 2026 holdings
- Shares (Q2 2026)
- 307,500
- Value
- $1.20M
- % of portfolio
- <0.1%
- Quarters held
- 7
- Since Q3 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 307,500 | $1.20M | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 307,500 | $1.18M | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 307,500 | $1.15M | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 307,500 | $618.1K | <0.1% | +307,500 | New | Holders |
| Q2 2025 | 0 | $0 | 0.0% | −263,200−100.0% | Sold out | Holders |
| Q1 2025 | 263,200 | $358.0K | <0.1% | +25,800+10.9% | Added | Holders |
| Q4 2024 | 237,400 | $981.7K | <0.1% | +128,800+118.6% | Added | Holders |
| Q3 2024 | 108,600 | $293.2K | <0.1% | +108,600 | New | Holders |